Literature DB >> 8513336

The majority of G0 transgenic mice are derived from mosaic embryos.

C B Whitelaw1, A J Springbett, J Webster, J Clark.   

Abstract

Most transgenic mice are generated by the direct microinjection of DNA fragments into the pronuclei of fertilized eggs. It has been generally assumed that the majority of integration events occur prior to the first round of chromosomal DNA replication (Palmiter and Brinster, 1986). In this study we have determined by comparison of PCR, Southern blot and transmission frequencies that at least 62% of integration events generate a mosaic (somatic and/or germline) G0 transgenic mouse. Furthermore, the statistical probability of transgene-containing cells segregating to the various early embryo lineages implies that this is probably an underestimate of the true mosaic frequency. Thus, the majority of DNA injected into fertilized mouse eggs intergates after the first round of chromosomal DNA replication, therefore most G0 transgenic mice are derived from a mosaic embryo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513336     DOI: 10.1007/BF01977678

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  14 in total

Review 1.  Genetic manipulation of mammals and its application in reproductive biology.

Authors:  I Wilmut; M L Hooper; J P Simons
Journal:  J Reprod Fertil       Date:  1991-07

Review 2.  Transition from maternal to embryonic control in early mammalian development: a comparison of several species.

Authors:  N A Telford; A J Watson; G A Schultz
Journal:  Mol Reprod Dev       Date:  1990-05       Impact factor: 2.609

3.  A set of proteins showing cell cycle dependent modification in the early mouse embryo.

Authors:  S K Howlett
Journal:  Cell       Date:  1986-05-09       Impact factor: 41.582

Review 4.  Germ-line transformation of mice.

Authors:  R D Palmiter; R L Brinster
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

5.  Transferrin- and albumin-directed expression of growth-related peptides in transgenic sheep.

Authors:  C E Rexroad; K Mayo; D J Bolt; T H Elsasser; K F Miller; R R Behringer; R D Palmiter; R L Brinster
Journal:  J Anim Sci       Date:  1991-07       Impact factor: 3.159

6.  Early postimplantation embryo lethality due to DNA rearrangements in a transgenic mouse strain.

Authors:  L Covarrubias; Y Nishida; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice.

Authors:  C B Whitelaw; A L Archibald; S Harris; M McClenaghan; J P Simons; A J Clark
Journal:  Transgenic Res       Date:  1991-12       Impact factor: 2.788

9.  Position-independent expression of the ovine beta-lactoglobulin gene in transgenic mice.

Authors:  C B Whitelaw; S Harris; M McClenaghan; J P Simons; A J Clark
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

10.  Comparison of the whey acidic protein genes of the rat and mouse.

Authors:  S M Campbell; J M Rosen; L G Hennighausen; U Strech-Jurk; A E Sippel
Journal:  Nucleic Acids Res       Date:  1984-11-26       Impact factor: 16.971

View more
  25 in total

1.  Expression of the human insulin gene in the gastric G cells of transgenic mice.

Authors:  E Zhukova; A Afshar; J Ko; P Popper; T Pham; C Sternini; J H Walsh
Journal:  Transgenic Res       Date:  2001-08       Impact factor: 2.788

Review 2.  The transgenic animal platform for biopharmaceutical production.

Authors:  L R Bertolini; H Meade; C R Lazzarotto; L T Martins; K C Tavares; M Bertolini; J D Murray
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

3.  Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; Lajos Mátés; Tien Yin Yau; Vladimír Landa; Vaclav Zidek; Sanum Bashir; Orsolya I Hoffmann; László Hiripi; Wiebke Garrels; Wilfried A Kues; Zsuzsanna Bösze; Aron Geurts; Michal Pravenec; Thomas Rülicke; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

4.  Introduction of a proximal Stat5 site in the murine alpha-lactalbumin promoter induces prolactin dependency in vitro and improves expression frequency in vivo.

Authors:  S Soulier; L Lepourry; M G Stinnakre; B Langley; P J L'Huillier; J Paly; J Djiane; J C Mercier; J L Vilotte
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

Review 5.  Improving the generation of genomic-type transgenic mice by ICSI.

Authors:  Pedro N Moreira; Julio Pozueta; Miriam Pérez-Crespo; Fernando Valdivieso; Alfonso Gutiérrez-Adán; Lluís Montoliu
Journal:  Transgenic Res       Date:  2007-02-16       Impact factor: 2.788

6.  The chicken hypersensitive site-4 insulator cannot fully shield the murine phosphoglycerate kinase-1 promoter from integration site effects in transgenic mice.

Authors:  Fatemeh Farzaneh; Zohreh Mirzapoor; Ehsan Jahangirian; Farid Heidari; Ehsan Hashemi; Aidin Rahim-Tayefeh; Nayeralsadat Fatemi; Abbas Jamshidizad; Mojtaba Dashtizad; Mehdi Shamsara
Journal:  3 Biotech       Date:  2019-06-07       Impact factor: 2.406

7.  Expression of bacterial cysteine biosynthesis genes in transgenic mice and sheep: toward a new in vivo amino acid biosynthesis pathway and improved wool growth.

Authors:  C S Bawden; A V Sivaprasad; P J Verma; S K Walker; G E Rogers
Journal:  Transgenic Res       Date:  1995-03       Impact factor: 2.788

8.  Goat RSPO1 over-expression rescues sex-reversal in Rspo1-knockout XX mice but does not perturb testis differentiation in XY or sex-reversed XX mice.

Authors:  Laurine Buscara; Fatemeh Montazer-Torbati; Sead Chadi; Aurélie Auguste; Johann Laubier; Anne-Amandine Chassot; Lauriane Renault; Bruno Passet; José Costa; Maëlle Pannetier; Marthe Vilotte; Marie-Christine Chaboissier; Jean-Luc Vilotte; Eric Pailhoux; Fabienne Le Provost
Journal:  Transgenic Res       Date:  2009-01-30       Impact factor: 2.788

Review 9.  Novel approaches to models of Alzheimer's disease pathology for drug screening and development.

Authors:  Laura Shaughnessy; Beth Chamblin; Lori McMahon; Ayyappan Nair; Mary Beth Thomas; John Wakefield; Frank Koentgen; Ram Ramabhadran
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Gene transfer efficiency during gestation and the influence of co-transfer of non-manipulated embryos on production of transgenic mice.

Authors:  R S Canseco; A E Sparks; R L Page; C G Russell; J L Johnson; W H Velander; R E Pearson; W N Drohan; F C Gwazdauskas
Journal:  Transgenic Res       Date:  1994-01       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.